NCT00003263View on ClinicalTrials.gov

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 1996

Primary Completion Date

December 31, 1999

Study Completion Date

November 30, 2000

Conditions
Malignant Mesothelioma
Interventions
BIOLOGICAL

recombinant interferon alfa

vaccine

DRUG

cisplatin

PROCEDURE

surgical procedure

RADIATION

radiation therapy

Trial Locations (3)

19111

Fox Chase Cancer Center, Philadelphia

23606

Virginia Oncology Associates, Newport News

70072

Office of S. Terry Kraus, Marrero

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00003263 - Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter